| 000 | 01627 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512004324.0 | ||
| 264 | 0 | _c19890522 | |
| 008 | 198905s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRenlund, D G | |
| 245 | 0 | 0 |
_aA prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. _h[electronic resource] |
| 260 |
_bTransplantation _cApr 1989 |
||
| 300 |
_a599-605 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 |
_aCyclosporins _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _ximmunology |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aO'Connell, J B | |
| 700 | 1 | _aGilbert, E M | |
| 700 | 1 | _aHammond, M E | |
| 700 | 1 | _aBurton, N A | |
| 700 | 1 | _aJones, K W | |
| 700 | 1 | _aKarwande, S V | |
| 700 | 1 | _aDoty, D B | |
| 700 | 1 | _aMenlove, R L | |
| 700 | 1 | _aHerrick, C M | |
| 773 | 0 |
_tTransplantation _gvol. 47 _gno. 4 _gp. 599-605 |
|
| 999 |
_c2529068 _d2529068 |
||